Published in Anticancer Res on April 03, 2008
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer. J Clin Oncol (2011) 3.31
BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis. J Clin Endocrinol Metab (2012) 1.39
Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon. J Clin Endocrinol Metab (2012) 1.13
Identification of Driving ALK Fusion Genes and Genomic Landscape of Medullary Thyroid Cancer. PLoS Genet (2015) 1.02
p53 suppresses carcinoma progression by inhibiting mTOR pathway activation. Oncogene (2014) 0.94
Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: a meta-analysis. World J Surg Oncol (2016) 0.86
Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: report of a case. Surg Today (2009) 0.86
Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients. J Korean Med Sci (2014) 0.85
The association between BRAF (V600E) mutation and pathological features in PTC. Eur Arch Otorhinolaryngol (2014) 0.84
A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma. Nat Rev Endocrinol (2016) 0.83
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers. Curr Genomics (2011) 0.82
Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. PLoS One (2015) 0.81
Mutation Profile of Well-Differentiated Thyroid Cancer in Asians. Endocrinol Metab (Seoul) (2015) 0.77
Putative BRAF activating fusion in a medullary thyroid cancer. Cold Spring Harb Mol Case Stud (2016) 0.77
Association between the KRAS Gene Polymorphisms and Papillary Thyroid Carcinoma in a Chinese Han Population. J Cancer (2016) 0.75
A Brief Review on The Molecular Basis of Medullary Tyroid Carcinoma. Cell J (2016) 0.75
Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis. J Korean Med Sci (2017) 0.75
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet (2008) 5.05
Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog (2011) 2.53
Rosacea: a clinicopathological approach. Dermatology (2004) 2.20
Mycobacterium avium subsp. paratuberculosis, genetic susceptibility to Crohn's disease, and Sardinians: the way ahead. J Clin Microbiol (2005) 1.82
Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol (2006) 1.80
Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet (2010) 1.72
Relation between common polymorphisms in genes related to inflammatory response and colorectal cancer. World J Gastroenterol (2006) 1.52
Comparison of monopolar electrocoagulation, bipolar electrocoagulation, Ultracision, and Ligasure. Surg Today (2006) 1.47
miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis. Inflamm Bowel Dis (2015) 1.47
Elucidation of cytomegalovirus disease recurrence in an HIV-1-positive patient. J Gastroenterol (2003) 1.38
Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications. World J Gastroenterol (2005) 1.28
Inflammatory pseudotumor associated with Mycobacterium tuberculosis infection. Int J Infect Dis (2008) 1.27
Expression of microRNAs in patients with pancreatic cancer and its prognostic significance. Pancreas (2013) 1.26
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Giant adrenal myelolipoma, a rare urological issue with increasing incidence: a case report. Cases J (2009) 1.14
Modified Bascom's asymmetric midgluteal cleft closure technique for recurrent pilonidal disease: early experience in a military hospital. Dis Colon Rectum (2003) 1.11
Relationship between Crohn's disease, infection with Mycobacterium avium subspecies paratuberculosis and SLC11A1 gene polymorphisms in Sardinian patients. World J Gastroenterol (2006) 1.09
Assessment of JC polyoma virus in colon neoplasms. Dis Colon Rectum (2005) 1.08
Breast angiosarcoma that is not related to radiation exposure: a comprehensive review of the literature. Surg Today (2011) 1.07
Detection of Mycobacterium avium subsp. paratuberculosis in retail cheeses from Greece and the Czech Republic. Appl Environ Microbiol (2005) 1.05
Micro-RNAs as regulators and possible diagnostic bio-markers in inflammatory bowel disease. J Crohns Colitis (2011) 1.04
Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer. Gastric Cancer (2007) 1.03
Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. BJU Int (2005) 1.03
Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog (2009) 1.02
A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas (2012) 1.01
The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue. Anticancer Res (2006) 1.00
Linking chronic infection and autoimmune diseases: Mycobacterium avium subspecies paratuberculosis, SLC11A1 polymorphisms and type-1 diabetes mellitus. PLoS One (2009) 0.99
Pseudosarcomatous myofibroblastic lesion of the urinary bladder: a rare entity posing a diagnostic challenge and therapeutic dilemma. Diagn Pathol (2008) 0.97
G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. Breast Cancer Res Treat (2007) 0.97
Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer (2005) 0.97
Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis. Int J Colorectal Dis (2011) 0.96
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium. Dig Liver Dis (2012) 0.95
Stem cells in colon cancer. A new era in cancer theory begins. Int J Colorectal Dis (2010) 0.95
Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome. Hum Pathol (2010) 0.94
Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol (2010) 0.94
Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors. Cancer Lett (2004) 0.93
Mucinous tubular and spindle cell carcinoma of the kidney: a case report. Case Rep Oncol (2012) 0.91
Immunohistochemical evaluation of immune response in invasive ductal breast cancer of not-otherwise-specified type. Breast (2003) 0.91
EGFR alterations in pancreatic ductal adenocarcinoma: a chromogenic in situ hybridization analysis based on tissue microarrays. Hepatogastroenterology (2006) 0.90
Direct detection of unamplified DNA from pathogenic mycobacteria using DNA-derivatized gold nanoparticles. J Microbiol Methods (2009) 0.90
Interdigitating dendritic cell sarcoma/tumour of the tonsil. Br J Haematol (2005) 0.90
Association of the miR-146aC>G, miR-149T>C, and miR-196a2T>C polymorphisms with gastric cancer risk and survival in the Greek population. Mol Biol Rep (2013) 0.90
Comparison of chromogenic in situ hybridisation with fluorescence in situ hybridisation and immunohistochemistry for the assessment of her-2/neu oncogene in archival material of breast carcinoma. Acta Histochem Cytochem (2008) 0.90
HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy. J Transl Med (2012) 0.89
Long-term plasma ghrelin and leptin modulation after sleeve gastrectomy in Wistar rats in comparison with gastric tissue ghrelin expression. Obes Surg (2011) 0.89
Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer. Int J Colorectal Dis (2005) 0.89
HSP90, HSPA8, HIF-1 alpha and HSP70-2 polymorphisms in breast cancer: a case-control study. Mol Biol Rep (2012) 0.88
Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease. World J Gastroenterol (2005) 0.88
Detection of pathogenic mycobacteria based on functionalized quantum dots coupled with immunomagnetic separation. PLoS One (2011) 0.88
Effects of caspase-9 and survivin gene polymorphisms in pancreatic cancer risk and tumor characteristics. Pancreas (2010) 0.88
The rs10830963 variant of melatonin receptor MTNR1B is associated with increased risk for gestational diabetes mellitus in a Greek population. Hormones (Athens) (2012) 0.87
Immunohistochemical detection of gastrin releasing peptide in patients with prostate cancer. World J Urol (2003) 0.86
Comparative evaluation of PCR assays for the robust molecular detection of Mycobacterium avium subsp. paratuberculosis. J Microbiol Methods (2004) 0.86
Quantum dots hold promise for early cancer imaging and detection. Int J Cancer (2012) 0.86
The role of microRNAs in liver cancer. Eur J Gastroenterol Hepatol (2012) 0.86
Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res (2009) 0.86
Simultaneous evaluation of maspin and CXCR4 in patients with breast cancer. J Clin Pathol (2006) 0.86
Expression of clock genes in patients with colorectal cancer. Int J Biol Markers (2013) 0.86
Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease. Inflamm Bowel Dis (2008) 0.86
Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast (2012) 0.86
Immunohistochemical evaluation of 95 bone marrow reactive plasmacytoses. Pathol Oncol Res (2008) 0.85
5-HT2A receptor gene polymorphisms and irritable bowel syndrome. J Clin Gastroenterol (2011) 0.85
Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer. Cancer Cell Int (2007) 0.85
T cell lymphoblastic lymphoma in parotidectomy for Warthin's tumor: case report and review of the literature. Int J Hematol (2009) 0.85
Association of the clock genes polymorphisms with colorectal cancer susceptibility. J Surg Oncol (2013) 0.85
Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns Colitis (2010) 0.85
Evaluation of dHPLC in mutation screening of the APC gene in a Greek FAP cohort. Anticancer Res (2003) 0.85
Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome. Gynecol Endocrinol (2008) 0.85
Vascular endothelial growth factor and endoglin expression in colorectal cancer. J Cancer Res Clin Oncol (2009) 0.84
Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia. Urology (2006) 0.84
DNA methylation profile of genes involved in inflammation and autoimmunity in inflammatory bowel disease. Medicine (Baltimore) (2014) 0.84
NUCKS overexpression in breast cancer. Cancer Cell Int (2009) 0.84
Muscle metastasis from hepatocellular carcinoma. J Cancer Res Ther (2011) 0.84
NRAMP1 polymorphism and viral factors in Sardinian multiple sclerosis patients. Can J Neurol Sci (2008) 0.84
Caspase 8 and caspase 9 gene polymorphisms and susceptibility to gastric cancer. Gastric Cancer (2011) 0.83
The role of genes in the development of Mullerian anomalies: where are we today? Obstet Gynecol Surv (2009) 0.83
High concentrations of reactive oxygen species in the BAL fluid are correlated with lung injury in rabbits after hemorrhagic shock and resuscitation. Tohoku J Exp Med (2009) 0.83
Heart dysfunction induced by choline-deficiency in adult rats: the protective role of L-carnitine. Eur J Pharmacol (2013) 0.83
Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia. Virchows Arch (2007) 0.83
MicroRNA gene polymorphisms in pancreatic cancer. Pancreatology (2013) 0.83
Multidrug resistance proteins and topoisomerase IIalpha expression in colon cancer: association with metastatic potential. Pathology (2003) 0.83
Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications. Urol Res (2002) 0.82
Current advantages in the application of proteomics in inflammatory bowel disease. Dig Dis Sci (2012) 0.82
The major circadian pacemaker ARNT-like protein-1 (BMAL1) is associated with susceptibility to gestational diabetes mellitus. Diabetes Res Clin Pract (2012) 0.82
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations. Cancer Epidemiol Biomarkers Prev (2012) 0.81
Pancreatic neuroendocrine tumors: current opinions on a rare, but potentially curable neoplasm. Eur J Gastroenterol Hepatol (2014) 0.81
Nitrosative and oxidative stresses contribute to post-ischemic liver injury following severe hemorrhagic shock: the role of hypoxemic resuscitation. PLoS One (2012) 0.81
Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact? Gynecol Endocrinol (2010) 0.81
Clinicopathological aspects of 18 Kaposi's sarcoma among 1055 Greek renal transplant recipients. Artif Organs (2004) 0.81
Heat shock protein90 in lobular neoplasia of the breast. BMC Cancer (2008) 0.81
Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk. Med Oncol (2014) 0.81
CD56 as a useful marker in the regenerative process of the histological progression of primary biliary cirrhosis. Eur J Gastroenterol Hepatol (2008) 0.81
Significance of cyclooxygenase 2, EZH-2 polycomb group and p53 expression in actinic keratosis and squamous cell carcinomas of the skin. Am J Dermatopathol (2013) 0.80